Results 111 to 120 of about 131,768 (282)

Neonates born at term with periventricular haemorrhagic infarction: Risk factors and clinical presentation

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
This case series describes infants born near term with periventricular hemorrhagic infarction (PVHI), highlighting seizures as a common early symptom. Neonatal complications during delivery and pro‐thrombotic genetic mutations were slightly more common. MRI‐classified involvement was predominantly in the caudate vein territory.
Aleksandra Zaykova   +6 more
wiley   +1 more source

Reorganized subtotal perfusion blockade of a pulmonary artery without hypertension after successfully lysed massive PE – A case report

open access: yesPulmonary Circulation
We present the case of an 18‐year‐old woman with a 5‐day history of thoracic pain and dyspnea following physical exertion, along with swelling of her right calf.
Hendrik Scheidhauer   +3 more
doaj   +1 more source

Transcatheter closure of Ventricular Septal defects in Malta : initial experience [PDF]

open access: yes, 2005
Ventricular septal defects (VSD) consist of deficiencies of the wall separating the two ventricles. VSDs are the commonest congenital cardiac defects. Small VSDs rarely require intervention, however, larger defects cause ventricular volume overload with ...
Aquilina, Oscar   +6 more
core  

Association between CMR‐derived hepatic T1‐time, tricuspid regurgitation and survival

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
We investigated the association between tricuspid regurgitation (TR) severity and hepatic T1‐time in 1029 patients undergoing cardiac MRI and echocardiography. Hepatic T1‐time increased progressively with TR severity and remained independently associated after adjusting for NT‐proBNP and right ventricular function. Both TR and hepatic T1‐time predicted
Katharina Mascherbauer   +19 more
wiley   +1 more source

Age‐related differences in cardiogenic shock secondary to Takotsubo syndrome

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
In this multicenter study of 408 patients with cardiogenic shock secondary to Takotsubo syndrome (CS‐TTS), age emerged as a major determinant of clinical profile and prognosis, along with SCAI shock stage. Younger patients presented with more atypical features and received more intensive support but had better short‐ and long‐term outcomes.
Marco Tomasino   +21 more
wiley   +1 more source

Albumin, urea‐to‐albumin ratio, or the albumin‐to‐creatinine ratio to predict outcomes in heart failure with mildly reduced ejection fraction

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Among 2061 hospitalized HFmrEF patients, low albumin, albumin‐to‐creatinine ratios (ACR), and elevated urea‐to‐albumin ratios (UAR) independently predicted long‐term all‐cause mortality, but not HF‐related rehospitalization. The UAR and ACR did not provide a clinically significant predictive advantage over albumin levels alone. Abstract Background This
Alexander Schmitt   +11 more
wiley   +1 more source

Persistent headache after aneurysmal subarachnoid hemorrhage: Prevalence, characteristics, and migraine history as a prognostic factor

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Persistent headache (PH) after an aneurysmal subarachnoid hemorrhage (aSAH) and the influence of migraine history (MH) on its evolution and prognosis is poorly understood. Our study aims are to (1) determine the prevalence, characteristics, and prognostic factors of PH after aSAH; and (2) study the impact of personal MH ...
Laura Gómez‐Dabó   +9 more
wiley   +1 more source

Can atogepant be a preventive treatment for cluster headache?—Insights from a case series

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Cluster headache (CH) is a disabling primary headache disorder with limited therapeutic options. Calcitonin gene‐related peptide (CGRP) is known to be involved in CH pathophysiology; however, except for galcanezumab (300 mg) in episodic CH, anti‐CGRP monoclonal antibodies did not reduce CH attacks in randomized clinical trials. Atogepant is an
Catarina Serrão   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy